These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 4133095

  • 21. Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated).
    Devi SJ, Schneerson R, Egan W, Vann WF, Robbins JB, Shiloach J.
    Infect Immun; 1991 Feb; 59(2):732-6. PubMed ID: 1898915
    [Abstract] [Full Text] [Related]

  • 22. Recurrent meningococcal infection with an antigenically identical strain.
    Griffiss JM, Bannatyne RM, Artenstein MS, Anglin CS.
    JAMA; 1974 Jul 01; 229(1):68-70. PubMed ID: 4134964
    [No Abstract] [Full Text] [Related]

  • 23. Computerized complex typing of Escherichia coli strains from different clinical materials.
    Czirók E, Herpay M, Milch H.
    Acta Microbiol Hung; 1993 Jul 01; 40(3):217-37. PubMed ID: 8191867
    [Abstract] [Full Text] [Related]

  • 24. [Infant enteritis due to Coli. IV. Enteropathogenic and normal Coli strains].
    Metz H.
    Zentralbl Bakteriol Orig A; 1972 Apr 01; 219(4):459-64. PubMed ID: 4145480
    [No Abstract] [Full Text] [Related]

  • 25. Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.
    Devi SJ, Robbins JB, Schneerson R.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):7175-9. PubMed ID: 1908091
    [Abstract] [Full Text] [Related]

  • 26. Escherichia coli K51 and K93 capsular polysaccharides are crossreactive with the group A capsular polysaccharide of Neisseria meningitidis. Immunochemical, biological, and epidemiological studies.
    Guirguis N, Schneerson R, Bax A, Egan W, Robbins JB, Shiloach J, Orskov I, Orskov F, el Kholy A.
    J Exp Med; 1985 Dec 01; 162(6):1837-51. PubMed ID: 3934317
    [Abstract] [Full Text] [Related]

  • 27. Elaboration of both the group W135 and group Y capsular polysccharides by a single strain of Neisseria meningitidis.
    Brandt BL, Pier GB, Goroff DK, Altieri PL, Griffiss JM.
    J Gen Microbiol; 1980 May 01; 118(1):39-43. PubMed ID: 6775049
    [Abstract] [Full Text] [Related]

  • 28. Apparent emergence of aminoglycoside-resistant Escherichia coli during neonatal meningitis.
    Echeverria P, Lew MA, Smith AL.
    N Engl J Med; 1975 Oct 30; 293(18):913-4. PubMed ID: 1101060
    [No Abstract] [Full Text] [Related]

  • 29. E. coli meningitis: K1 antigen and virulence.
    Wilfert CM.
    Annu Rev Med; 1978 Oct 30; 29():129-36. PubMed ID: 348030
    [Abstract] [Full Text] [Related]

  • 30. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide. II. Specificity.
    Rubinstein LJ, Stein KE.
    J Immunol; 1988 Dec 15; 141(12):4357-62. PubMed ID: 3143763
    [Abstract] [Full Text] [Related]

  • 31. Comparative immunogenicity of vaccines prepared from capsular polysaccharides of group C Neisseria meningitidis O-acetyl-positive and O-acetyl-negative variants and Escherichia coli K92 in adult volunteers.
    Glode MP, Lewin EB, Sutton A, Le CT, Gotschlich EC, Robbins JB.
    J Infect Dis; 1979 Jan 15; 139(1):52-9. PubMed ID: 108338
    [Abstract] [Full Text] [Related]

  • 32. Are antibodies to the capsular polysaccharide of Neisseria meningitidis group B and Escherichia coli K1 associated with immunopathology?
    Stein DM, Robbins J, Miller MA, Lin FY, Schneerson R.
    Vaccine; 2006 Jan 16; 24(3):221-8. PubMed ID: 16125824
    [Abstract] [Full Text] [Related]

  • 33. Editorial: Fecal flora and resistance to invasive bacteria.
    Anderson P.
    N Engl J Med; 1975 May 22; 292(21):1124-5. PubMed ID: 1093021
    [No Abstract] [Full Text] [Related]

  • 34. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.
    Finne J, Leinonen M, Mäkelä PH.
    Lancet; 1983 Aug 13; 2(8346):355-7. PubMed ID: 6135869
    [Abstract] [Full Text] [Related]

  • 35. Virulence factors and O groups of Escherichia coli strains isolated from cultures of blood specimens from urosepsis and non-urosepsis patients.
    Blanco M, Blanco JE, Alonso MP, Blanco J.
    Microbiologia; 1994 Sep 13; 10(3):249-56. PubMed ID: 7532950
    [Abstract] [Full Text] [Related]

  • 36. Esch. coli infections in childhood. Significance of bacterial virulence and immune defence.
    Hanson LA.
    Arch Dis Child; 1976 Oct 13; 51(10):737-43. PubMed ID: 795381
    [Abstract] [Full Text] [Related]

  • 37. Group-specific polysaccharide antigen and humoral antibody response in disease due to Neisseria meningitidis.
    Hoffman TA, Edwards EA.
    J Infect Dis; 1972 Dec 13; 126(6):636-44. PubMed ID: 4123779
    [No Abstract] [Full Text] [Related]

  • 38. Activation of brain endothelium by Escherichia coli K1 virulence factor cglD promotes polymorphonuclear leukocyte transendothelial migration.
    Zhang K, Shi MJ, Niu Z, Chen X, Wei JY, Miao ZW, Zhao WD, Chen YH.
    Med Microbiol Immunol; 2019 Feb 13; 208(1):59-68. PubMed ID: 30171337
    [Abstract] [Full Text] [Related]

  • 39. The importance of the K1 capsule in invasive infections caused by Escherichia coli.
    Cross AS, Gemski P, Sadoff JC, Orskov F, Orskov I.
    J Infect Dis; 1984 Feb 13; 149(2):184-93. PubMed ID: 6199436
    [Abstract] [Full Text] [Related]

  • 40. Dot-immunobinding assay with a monoclonal antibody for detection of group B meningococcal antigen.
    Coll P, Borche L, Ausina V, Mirelis B, Prats G.
    Eur J Clin Microbiol; 1986 Feb 13; 5(1):44-6. PubMed ID: 3084244
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.